A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection

Clinical trial NCT06679998 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06679998
Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Ischemic Stroke (AIS)

Start date: 2024-11-14
Primary completion: 2026-01-12
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.